InterMune (ITMN) Could Draw Bids as IPF Treatment Esbriet Gains Strength

Go back to InterMune (ITMN) Could Draw Bids as IPF Treatment Esbriet Gains Strength
Gilead Sciences (NASDAQ: GILD) Delayed: 144.23 -0.4 (0.28%)
Previous Close $144.63    52 Week High $108.63 
Open $145.11    52 Week Low $71.39 
Day High $146.14    P/E 79.69 
Day Low $142.60    EPS $1.81 
Volume 3,723,581       

GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 46.60 +0.05 (0.11%)
Previous Close $46.55    52 Week High $45.58 
Open $46.96    52 Week Low $37.82 
Day High $47.01    P/E N/A 
Day Low $46.18    EPS $0.00 
Volume 6,806,377       

InterMune, Inc. (NASDAQ: ITMN) Delayed: 73.89 --0 (-0%)
Previous Close $73.89    52 Week High $74.24 
Open $1.07    52 Week Low $10.95 
Day High $73.89    P/E N/A 
Day Low $73.89    EPS $-2.67 
Volume 5       

NOVARTIS AG (NYSE: NVS) Delayed: 140.79 -0.14 (0.1%)
Previous Close $140.93    52 Week High $89.15 
Open $141.32    52 Week Low $69.84 
Day High $141.39    P/E N/A 
Day Low $139.67    EPS $0.00 
Volume 1,574,410